{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T17:45:16Z","timestamp":1787939116596,"version":"build-2784847793"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T00:00:00Z","timestamp":1655683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T00:00:00Z","timestamp":1655683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Dysferlinopathy encompasses a group of rare muscular dystrophies caused by recessive mutations in the <jats:italic>DYSF<\/jats:italic> gene. The phenotype ranges from asymptomatic elevated serum creatine kinase (hyperCKemia) to selective and progressive involvement of the proximal and\/or distal muscles of the limbs. Bohan and Peter criteria are the most widely used for the diagnosis of polymyositis, but they have limitations and can misclassify muscular dystrophies with inflammation as polymyositis. Most dysferlinopathy patients have muscle biopsies with inflammation and thus are vulnerable to misdiagnosis with polymyositis and inappropriate treatment with steroids and immunosuppressors.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We describe a 14\u00a0years-old male patient who was referred for assessment of asymptomatic hyperCKemia (26,372\u00a0IU\/L). An X-linked dystrophinopathy initially was ruled out by direct genetic testing. Juvenile polymyositis was considered based on muscle biopsy, creatine kinase levels, and electromyography changes. Corticosteroid treatment triggered proximal lower limb muscular weakness, and no full muscular strength recovery was observed after corticosteroid withdrawal. Based on these observations, a limb-girdle muscular dystrophy (LGMD) was suspected, and LGMDR2 was confirmed by whole exome sequencing.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>We report a dysferlinopathy patient who was misdiagnosed with juvenile polymyositis and explore in a literature review how common such misdiagnoses are. With diagnosis based only on routine clinicopathological examinations, distinguishing an inflammatory myopathy from dysferlinopathy is quite difficult. We suggest that before establishing a diagnosis of \u201cdefinite\u201d or \u201cprobable\u201d juvenile polymyositis, according to Bohan and Peter or current ACR\/EULAR criteria, a muscular dystrophy must first be ruled out.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12920-022-01284-y","type":"journal-article","created":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T11:09:04Z","timestamp":1655723344000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Dysferlinopathy misdiagnosed with juvenile polymyositis in the pre-symptomatic stage of hyperCKemia: a case report and literature review"],"prefix":"10.1186","volume":"15","author":[{"given":"Cecilia","family":"Contreras-Cubas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Barajas-Olmos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria In\u00e9s","family":"Frayre-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina","family":"Siordia-Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia C.","family":"Gu\u00edzar-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humberto","family":"Garc\u00eda-Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Orozco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2501-3719","authenticated-orcid":false,"given":"Vicente","family":"Baca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,20]]},"reference":[{"issue":"6936","key":"1284_CR1","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nature01573","volume":"423","author":"D Bansal","year":"2003","unstructured":"Bansal D, Miyake K, Vogel SS, Groh S, Chen CC, Williamson R, et al. Defective membrane repair in Dysferlin-deficient muscular dystrophy. Nature. 2003;423(6936):168\u201372.","journal-title":"Nature"},{"issue":"8","key":"1284_CR2","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.nmd.2018.05.007","volume":"28","author":"V Straub","year":"2018","unstructured":"Straub V, Murphy A, Udd B, LGMD Workshop Study Group. 229th ENMC international workshop: limb girdle muscular dystrophies\u2014nomenclature and reformed classification Naarden, the Netherlands. Neuromuscul Disord. 2018;28(8):702\u201310.","journal-title":"Neuromuscul Disord"},{"issue":"8","key":"1284_CR3","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1001\/archneur.64.8.1176","volume":"64","author":"K Nguyen","year":"2007","unstructured":"Nguyen K, Bassez G, Krahn M, Bernard R, Lafor\u00eat P, et al. Phenotypic study in 40 patients with Dysferlin gene mutations: high frequencyof atypical phenotypes. Arch Neurol. 2007;64(8):1176\u201382.","journal-title":"Arch Neurol"},{"issue":"5","key":"1284_CR4","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1002\/mus.25367","volume":"54","author":"M Fanin","year":"2016","unstructured":"Fanin M, Angelini C. Progress and challenges in diagnosis of dysferlinopathy. Muscle Nerve. 2016;54(5):821\u201335.","journal-title":"Muscle Nerve"},{"issue":"4","key":"1284_CR5","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.pcl.2018.04.006","volume":"65","author":"AM Huber","year":"2018","unstructured":"Huber AM. Juvenile idiopathic inflammatory myopathies. Pediatr Clin North Am. 2018;65(4):739\u201356.","journal-title":"Pediatr Clin North Am"},{"issue":"7","key":"1284_CR6","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292(7):344\u20137.","journal-title":"N Engl J Med"},{"issue":"7","key":"1284_CR7","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med. 1975;292(7):403\u20137.","journal-title":"N Engl J Med"},{"issue":"12","key":"1284_CR8","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","volume":"76","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE, Tj\u00e4rnlund A, Bottai M, Werth VP, Pilkington C, Visser M, et al. 2017 European League against Rheumatism\/American college of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis. 2017;76(12):1955\u201364.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1284_CR9","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1093\/rheumatology\/key343","volume":"58","author":"MJS Parker","year":"2019","unstructured":"Parker MJS, Oldroyd A, Roberts ME, Lilleker JB, Betteridge ZE, McHugh NJ, et al. The performance of the European League against Rheumatism\/American college of Rheumatology idiopathic inflammatory myopathies classification criteria in an expert-defined 10 year incident cohort. Rheumatology. 2019;58(3):468\u201375 (Oxford).","journal-title":"Rheumatology"},{"issue":"7","key":"1284_CR10","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1093\/rheumatology\/keaa801","volume":"60","author":"J Loarce-Martos","year":"2021","unstructured":"Loarce-Martos J, Lilleker JB, Parker M, McHugh N, Chinoy H. Polymyositis: is there anything left. A retrospective diagnostic review from a tertiary myositis centre. Rheumatology. 2021;60(7):3398\u2013403 (Oxford).","journal-title":"Rheumatology"},{"issue":"3","key":"1284_CR11","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1212\/WNL.61.3.316","volume":"61","author":"MF van der Meulen","year":"2003","unstructured":"van der Meulen MF, Bronner IM, Hoogendijk JE, Burger H, van Venrooij WJ, Voskuyl AE, Dinant HJ, et al. Polymyositis: an overdiagnosed entity. Neurology. 2003;61(3):316\u201321.","journal-title":"Neurology"},{"issue":"3","key":"1284_CR12","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1212\/WNL.61.3.288","volume":"61","author":"AA Amato","year":"2003","unstructured":"Amato AA, Griggs RC. Unicorns, dragons, polymyositis, and other mythological beasts. Neurology. 2003;61(3):288\u20139.","journal-title":"Neurology"},{"issue":"12","key":"1284_CR13","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1001\/jamaneurol.2018.2598","volume":"75","author":"K Mariampillai","year":"2018","unstructured":"Mariampillai K, Granger B, Amelin D, Guiguet M, Hachulla E, Maurier F, et al. Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies. JAMA Neurol. 2018;75(12):1528\u201337.","journal-title":"JAMA Neurol"},{"issue":"4","key":"1284_CR14","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S0889-857X(02)00031-5","volume":"28","author":"EP Hoffman","year":"2002","unstructured":"Hoffman EP, Rao D, Pachman LM. Clarifying the boundaries between the inflammatory and dystrophic myopathies: insights from molecular diagnostics and microarrays. Rheum Dis Clin North Am. 2002;28(4):743\u201357.","journal-title":"Rheum Dis Clin North Am"},{"issue":"6","key":"1284_CR15","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1097\/BOR.0000000000000837","volume":"33","author":"V Leclair","year":"2021","unstructured":"Leclair V, Notarnicola A, Vencovsky J, Lundberg IE. Polymyositis: does it really exist as a distinct clinical subset? Curr Opin Rheumatol. 2021;33(6):537\u201343.","journal-title":"Curr Opin Rheumatol"},{"issue":"4 Pt 2","key":"1284_CR16","doi-asserted-by":"publisher","first-page":"e249","DOI":"10.1016\/j.lpm.2010.11.023","volume":"40","author":"O Benveniste","year":"2011","unstructured":"Benveniste O, Romero NB. Myositis or dystrophy. Traps and pitfalls. Presse Med. 2011;40(4 Pt 2):e249\u201355.","journal-title":"Presse Med"},{"issue":"4","key":"1284_CR17","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/j.1365-2559.2009.03407.x","volume":"55","author":"CE D'Arcy","year":"2009","unstructured":"D\u2019Arcy CE, Ryan MM, McLean CA. Juvenile polymyositis or paediatric muscular dystrophy: a detailed re-analysis of 13 cases. Histopathology. 2009;55(4):452\u201362.","journal-title":"Histopathology"},{"issue":"10","key":"1284_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11926-015-0541-0","volume":"17","author":"EH Michelle","year":"2015","unstructured":"Michelle EH, Mammen AL. Myositis mimics. Curr Rheumatol Rep. 2015;17(10):63.","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"1284_CR19","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1097\/BOR.0000000000000441","volume":"29","author":"AL Mammen","year":"2017","unstructured":"Mammen AL. Which nonautoimmune myopathies are most frequently misdiagnosed as myositis? Curr Opin Rheumatol. 2017;29(6):618\u201322.","journal-title":"Curr Opin Rheumatol"},{"issue":"11","key":"1284_CR20","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1212\/WNL.57.11.2136","volume":"57","author":"E Gallardo","year":"2001","unstructured":"Gallardo E, Rojas-Garc\u00eda R, de Luna N, Pou A, Brown RH Jr, Illa I. Inflammation in Dysferlin myopathy: immunohistochemical characterization of 13 patients. Neurology. 2001;57(11):2136\u20138.","journal-title":"Neurology"},{"issue":"6","key":"1284_CR21","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1046\/j.1365-2990.2002.00417.x","volume":"28","author":"M Fanin","year":"2002","unstructured":"Fanin M, Angelini C. Muscle pathology in Dysferlin deficiency. Neuropathol Appl Neurobiol. 2002;28(6):461\u201370.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"6\u20137","key":"1284_CR22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S0960-8966(99)00041-3","volume":"9","author":"J Rowin","year":"1999","unstructured":"Rowin J, Meriggioli MN, Cochran EJ, Sanders DB. Prominent inflammatory changes on muscle biopsy in patients with Miyoshi myopathy. Neuromuscul Disord. 1999;9(6\u20137):417\u201320.","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"1284_CR23","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1212\/NXG.0000000000000089","volume":"2","author":"E Harris","year":"2016","unstructured":"Harris E, Bladen CL, Mayhew A, James M, Bettinson K, et al. The clinical outcome study for dysferlinopathy: an international multicenter study. Neurol Genet. 2016;2(4):e89.","journal-title":"Neurol Genet"},{"key":"1284_CR24","doi-asserted-by":"publisher","first-page":"724","DOI":"10.3346\/jkms.2006.21.4.724","volume":"21","author":"HJ Cho","year":"2006","unstructured":"Cho HJ, Sung DH, Kim EJ, Yoon CH, Ki CS, Kim JW. Clinical and genetic analysis of Korean patients with Miyoshi myopathy: identification of three novel mutations in the DYSF gene. J Korean Med Sci. 2006;21:724\u20137.","journal-title":"J Korean Med Sci"},{"key":"1284_CR25","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.nmd.2006.01.005","volume":"16","author":"A Selva-O'Callaghan","year":"2006","unstructured":"Selva-O\u2019Callaghan A, Labrador-Horrillo M, Gallardo E, Herruzo A, Grau-Junyent JM, Vilardell-Tarres M. Muscle inflammation, autoimmune Addison\u2019s disease and sarcoidosis in a patient with Dysferlin deficiency. Neuromuscul Disord. 2006;16:208\u20139.","journal-title":"Neuromuscul Disord"},{"key":"1284_CR26","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1590\/S0004-282X2008000100019","volume":"66","author":"LH Pimentel","year":"2008","unstructured":"Pimentel LH, Alc\u00e2ntara RN, Fontenele SM, Costa CM, Gondim FA. Limb-girdle muscular dystrophy type 2B mimicking polymyositis. Arq Neuropsiquiatr. 2008;66:80\u20132.","journal-title":"Arq Neuropsiquiatr"},{"key":"1284_CR27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10067-009-1273-1","volume":"29","author":"J Vinit","year":"2010","unstructured":"Vinit J, Samson M Jr, Gaultier JB, Laquerriere A, Ollagnon E, Petiot P, et al. Dysferlin deficiency treated like refractory polymyositis. Clin Rheumatol. 2010;29:103\u20136.","journal-title":"Clin Rheumatol"},{"key":"1284_CR28","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.nmd.2011.02.003","volume":"21","author":"L Vernengo","year":"2011","unstructured":"Vernengo L, Oliveira J, Krahn M, Vieira E, Santos R, Carrasco L, Negr\u00e3o L, et al. Novel ancestral Dysferlin splicing mutation which migrated from the Iberian peninsula to South America. Neuromuscul Disord. 2011;21:328\u201337.","journal-title":"Neuromuscul Disord"},{"key":"1284_CR29","first-page":"185","volume":"30","author":"C Angelini","year":"2011","unstructured":"Angelini C, Grisold W, Nigro V. Diagnosis by protein analysis of dysferlinopathy in two patients mistaken as polymyositis. Acta Myol. 2011;30:185\u20137.","journal-title":"Acta Myol"},{"key":"1284_CR30","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.nmd.2011.12.007","volume":"22","author":"YE Park","year":"2012","unstructured":"Park YE, Kim HS, Lee CH, Nam TS, Choi YC, Kim DS. Two common mutations (p.Gln832X and c.663+1G>C) account for about a third of the DYSF mutations in Korean patients with dysferlinopathy. Neuromuscul Disord. 2012;22:505\u201310.","journal-title":"Neuromuscul Disord"},{"key":"1284_CR31","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3346\/jkms.2012.27.4.423","volume":"27","author":"HJ Park","year":"2012","unstructured":"Park HJ, Hong JM, Suh GI, Shin HY, Kim SM, Sunwoo IN, et al. Heterogeneous characteristics of Korean patients with dysferlinopathy. J Korean Med Sci. 2012;27:423\u20139.","journal-title":"J Korean Med Sci"},{"key":"1284_CR32","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/RHU.0000000000000126","volume":"20","author":"F Li","year":"2014","unstructured":"Li F, Yin G, Xie Q, Shi G. Late-onset dysferlinopathy presented as \u201cliver enzyme\u201d abnormalities: a technical note. J Clin Rheumatol. 2014;20:275\u20137.","journal-title":"J Clin Rheumatol"},{"key":"1284_CR33","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.medcli.2014.12.009","volume":"145","author":"J Loureiro Amigo","year":"2015","unstructured":"Loureiro Amigo J, Gallardo E, Gallano P, Grau-Junyent JM. Disferlinopat\u00eda, una causa de falsa polimiositis refractaria [Dysferlinopathy masquerading as a refractory polymyositis]. Med Clin (Barc). 2015;145:414\u20135.","journal-title":"Med Clin (Barc)"},{"key":"1284_CR34","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jbspin.2015.03.017","volume":"83","author":"Z Griger","year":"2016","unstructured":"Griger Z, Nagy-Vincze M, Bodoki L, Gherardi RK, Dank\u00f3 K, Hortob\u00e1gyi T. Late onset dysferlinopathy mimicking treatment resistant polymyositis. Joint Bone Spine. 2016;83:355\u20136.","journal-title":"Joint Bone Spine"},{"key":"1284_CR35","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1017\/cjn.2015.386","volume":"43","author":"MA Tarnopolsky","year":"2016","unstructured":"Tarnopolsky MA, Hatcher E, Shupak R. Genetic myopathies initially diagnosed and treated as inflammatory myopathy. Can J Neurol Sci. 2016;43:381\u20134.","journal-title":"Can J Neurol Sci"},{"key":"1284_CR36","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.3892\/etm.2016.3716","volume":"12","author":"M Wang","year":"2016","unstructured":"Wang M, Guo Y, Fu Y, Jia R, Chen G. Atypical Miyoshi distal myopathy: a case report. Exp Ther Med. 2016;12:3068\u201372.","journal-title":"Exp Ther Med"},{"key":"1284_CR37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.12659\/AJCR.900970","volume":"18","author":"RS Scalco","year":"2017","unstructured":"Scalco RS, Lorenzoni PJ, Lynch DS, Martins WA, Jungbluth H, Quinlivan R, et al. Polymyositis without beneficial response to steroid therapy: should Miyoshi myopathy be a differential diagnosis? Am J Case Rep. 2017;18:17\u201321.","journal-title":"Am J Case Rep"},{"key":"1284_CR38","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1007\/s00393-017-0326-0","volume":"76","author":"G Ceccon","year":"2017","unstructured":"Ceccon G, Lehmann HC, Neuen-Jacob E, Meng G, Fink GR, Wunderlich G. Therapierefrakt\u00e4re Polymyositis\u201c\u2014stimmt die diagnose? \u201cTherapy-resistant polymyositis\u201d\u2014is the diagnosis correct? Z Rheumatol. 2017;76:640\u20133 (German).","journal-title":"Z Rheumatol"},{"key":"1284_CR39","doi-asserted-by":"publisher","first-page":"e10539","DOI":"10.1097\/MD.0000000000010539","volume":"97","author":"C Xu","year":"2018","unstructured":"Xu C, Chen J, Zhang Y, Li J. Limb-girdle muscular dystrophy type 2B misdiagnosed as polymyositis at the early stage: case report and literature review. Medicine. 2018;97:e10539 (Baltimore).","journal-title":"Medicine"},{"key":"1284_CR40","doi-asserted-by":"crossref","unstructured":"Tang J, Song X, Ji G, Wu H, Sun S, Lu S, et al. A novel mutation in the DYSF gene in a patient with a presumed inflammatory myopathy. Neuropathology. 2018.\u00a0","DOI":"10.1111\/neup.12474"},{"key":"1284_CR41","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1750-1172-8-26","volume":"8","author":"MC Walter","year":"2013","unstructured":"Walter MC, Reilich P, Thiele S, Schessl J, Schreiber H, Reiners K, et al. Treatment of dysferlinopathy with deflazacort: a double-blind, placebo-controlled clinical trial. Orphanet J Rare Dis. 2013;8:26.","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"1284_CR42","first-page":"1803","volume":"22","author":"SL Venance","year":"2016","unstructured":"Venance SL. Approach to the patient with HyperCKemia. Continuum (Minneap Minn). 2016;22(6):1803\u201314.","journal-title":"Continuum (Minneap Minn)"},{"issue":"1","key":"1284_CR43","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13023-017-0699-9","volume":"12","author":"E Harris","year":"2017","unstructured":"Harris E, Topf A, Barresi R, Hudson J, Powell H, Tellez J, et al. Exome sequences versus sequential gene testing in the UK highly specialised service for limb girdle muscular dystrophy. Orphanet J Rare Dis. 2017;12(1):151.","journal-title":"Orphanet J Rare Dis"},{"key":"1284_CR44","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1212\/WNL.57.2.271","volume":"57","author":"M Aoki","year":"2001","unstructured":"Aoki M, Liu J, Richard I, Bashir R, Britton S, et al. Genomic organization of the Dysferlin gene and novel mutations in Miyoshi myopathy. Neurology. 2001;57:271\u20138.","journal-title":"Neurology"},{"issue":"3","key":"1284_CR45","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/mus.22314","volume":"45","author":"B G\u00f3mez-D\u00edaz","year":"2012","unstructured":"G\u00f3mez-D\u00edaz B, Rosas-Vargas H, Roque-Ram\u00edrez B, Meza-Espinoza P, Ruano-Calder\u00f3n LA, Fern\u00e1ndez-Valverde F, et al. Immunodetection analysis of muscular dystrophies in Mexico. Muscle Nerve. 2012;45(3):338\u201345.","journal-title":"Muscle Nerve"},{"issue":"3","key":"1284_CR46","doi-asserted-by":"publisher","first-page":"276","DOI":"10.5114\/fn.2021.109426","volume":"59","author":"RE Escobar-Cedillo","year":"2021","unstructured":"Escobar-Cedillo RE, L\u00f3pez-Hern\u00e1ndez L, Miranda-Duarte A, Curiel-Leal MD, Suarez-Oc\u00f3n A, S\u00e1nchez-Chapul L, Berenice Luna-Angulo A, et al. Genetic analysis of muscular dystrophies: our experience in Mexico. Folia Neuropathol. 2021;59(3):276\u201383.","journal-title":"Folia Neuropathol"},{"key":"1284_CR47","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/humu.9355","volume":"26","author":"K Nguyen","year":"2005","unstructured":"Nguyen K, Bassez G, Bernard R, Krahn M, Labelle V, Figarella-Branger D, et al. Dysferlin mutations in LGMD2B, Miyoshi myopathy, and atypical dysferlinopathies. Hum Mutat. 2005;26:165.","journal-title":"Hum Mutat"},{"issue":"7759","key":"1284_CR48","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41586-019-1231-2","volume":"570","author":"J Flannick","year":"2019","unstructured":"Flannick J, Mercader JM, Fuchsberger C, Udler MS, Mahajan A, Wessel J, et al. Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls. Nature. 2019;570(7759):71\u20136.","journal-title":"Nature"},{"issue":"2","key":"1284_CR49","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/humu.21160","volume":"31","author":"N Wein","year":"2010","unstructured":"Wein N, Avril A, Bartoli M, Beley C, Chaouch S, Lafor\u00eat P, et al. Efficient bypass of mutations in Dysferlin deficient patient cells by antisense-induced exon skipping. Hum Mutat. 2010;31(2):136\u201342.","journal-title":"Hum Mutat"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-022-01284-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-022-01284-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-022-01284-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T12:05:10Z","timestamp":1655726710000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-022-01284-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,20]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1284"],"URL":"https:\/\/doi.org\/10.1186\/s12920-022-01284-y","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,20]]},"assertion":[{"value":"27 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was given by the Comit\u00e9 Local de Investigaci\u00f3n en Salud del Hospital de Pediatr\u00eda, Centro M\u00e9dico Nacional Siglo XXI, 2021-09-13 3603. Written informed consent was obtained from the patient and both parents.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient\u00b4s parents and the patient for publication of this case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"139"}}